微生物鑑定市場- 按產品和服務（儀器[PCR、質譜儀]、消耗品、軟體、服務）、方法（表現型、基因型）、應用（臨床診斷、製藥）、最終用途- 全球預測（2024 - 2032）

Microbial Identification Market - By Product and Services (Instrument [PCR, Mass Spectrometer], Consumable, Software, Service), Method (Phenotypic, Genotypic), Application (Clinical Diagnostics, Pharmaceuticals), End-use - Global Forecast (2024 - 2032)

出版日期: 2024年04月25日 | 出版商:

Global Market Insights Inc. | 英文 230 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在協作和夥伴關係的加強以及識別技術的技術進步的推動下，微生物識別市場規模預計從 2024 年到 2032 年將複合年成長率達到 8.8%。研究人員和公司正在結盟，以提高研究能力並擴大應用領域。基因組學和生物資訊學等技術創新也提高了微生物鑑定過程的準確性和速度。

不斷取得的進步進一步促進了對新興病原體的更快反應，並提高了醫療保健、農業和環境監測等各個行業的診斷精確度。例如，2023 年 4 月，JMI 實驗室和生物梅里埃合作進行抗菌素抗藥性診斷，以利用微生物鑑定的專業知識。此次合作有助於提高診斷能力並應對全球微生物抗藥性不斷變化的挑戰。

整個市場分為產品和服務、方法、應用、最終用途和區域。

在產品和服務方面，在基因組學和光譜學等尖端技術進步的推動下，微生物鑑定市場的儀器部分預計將在 2024 年至 2032 年期間實現顯著的複合年成長率。儀器有助於提高從醫療保健到農業等各個領域鑑定微生物的準確性和效率。人工智慧和自動化的整合以簡化流程和提高診斷速度等發展也使得能夠更快地回應新興病原體並促進個人化治療策略，從而促進該細分市場的成長。

從應用來看，製藥領域的微生物鑑定產業預計將在 2024 年至 2032 年期間成長。分子生物學技術和質譜分析正在提高藥物開發和製造過程中微生物鑑定的準確性和速度。製藥公司也正在最佳化生物資訊學和資料分析方面的品質控制措施和監管合規性，以主動管理微生物風險。

從地區來看，在人們對加強食品安全和擴大醫療基礎設施的日益關注的推動下，亞太地區微生物鑑定市場規模預計將在 2024 年至 2032 年間呈現強勁成長。 PCR和MALDI-TOF等先進技術被廣泛採用，以確保食品和臨床應用中微生物的精確鑑定。對醫療保健設施的投資正在加強提供更廣泛的先進診斷工具和加強區域醫療保健系統的努力，進一步推動亞太地區的產業擴張。

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Avantor, Inc.
bioMérieux SA
Becton, Dickinson and Company
Bruker Corporation
Beckman Coulter, Inc.
Biolog, Inc.
Charles River Laboratories International, Inc.
Eurofins Scientific
Merck KGaA
Qiagen N.V.
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Wickham Micro Limited

簡介目錄

Product Code: 9221

Microbial Identification Market size is projected to record 8.8% CAGR from 2024 to 2032, driven by increasing collaboration and partnerships alongside technological advancements in identification techniques. Researchers and companies are forging alliances to enhance research capabilities and expand application areas. Technological innovations, such as genomics and bioinformatics are also improving the accuracy and speed of microbial identification processes.

Growing advancements are further facilitating quicker responses to emerging pathogens and improving diagnostic precision in various industries, including healthcare, agriculture, and environmental monitoring. For instance, in April 2023, JMI Laboratories and bioMerieux partnered for antimicrobial resistance diagnostics for leveraging expertise in microbial identification. This collaboration helped in advancing diagnostic capabilities and addressing evolving challenges in microbial resistance globally.

The overall market is segregated into product and services, method, application, end-use, and region.

In terms of product and services, the instruments segment in the microbial identification market is expected to record significant CAGR from 2024 to 2032, propelled by advances in cutting-edge technologies like genomics and spectroscopy. Instruments help in enhancing accuracy and efficiency in identifying microorganisms across various sectors from healthcare to agriculture. Developments, such as integration of AI and automation to streamline processes and improve diagnostic speed are also enabling quicker responses to the emerging pathogens and facilitating personalized treatment strategies, adding to the segment growth.

By application, the microbial identification industry from the pharmaceuticals segment is projected to rise from 2024 to 2032. This is driven hefty investments by pharmaceutical companies on advanced microbial identification technologies to ensure product safety and efficacy. Molecular biology techniques and mass spectrometry are improving the accuracy and speed of microbial identification in drug development and manufacturing processes. Pharmaceuticals are also optimizing quality control measures and regulatory compliance in bioinformatics and data analytics for proactive management of microbial risks.

Regionally, the Asia Pacific microbial identification market size is projected to exhibit robust growth between 2024 and 2032, fueled by increasing attention on enhancing food safety and expanding healthcare infrastructure. Advanced technologies, such as PCR and MALDI-TOF are widely adopted to ensure precise microbial identification in both food and clinical applications. Investments in healthcare facilities are bolstering the efforts for providing broader access to advanced diagnostic tools and strengthening regional healthcare systems, further driving the industry expansion in APAC.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of infectious diseases
  - 3.2.1.2 Rising technological advancements
  - 3.2.1.3 Increasing awareness about food safety
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of automated microbial identification systems
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product and Services, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Instruments
- 5.2.1 Mass spectrometers
- 5.2.2 PCR systems
- 5.2.3 Microarrays
- 5.2.4 Other instruments
5.3 Consumables
- 5.3.1 Reagents and kits
- 5.3.2 Plates and media
5.4 Software
5.5 Services

Chapter 6 Market Estimates and Forecast, By Method, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Phenotypic methods
6.3 Genotypic methods
6.4 Proteotypic methods

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Clinical diagnostics
7.3 Pharmaceuticals
7.4 Cosmetic and personal care product testing
7.5 Food and beverage testing
7.6 Environmental application
7.7 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Pharmaceutical and biotechnology companies
8.3 Hospitals and diagnostic laboratories
8.4 Food testing laboratories
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa